Form 4: Axsome Therapeutics COO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Mark L. Jacobson, Chief Operating Officer of Axsome Therapeutics, Inc., sold 10,000 shares of common stock on September 3, 2026 for $208.65 per share.

Summary

  • Option exercise/conversion: acquired 10,000 Common Stock at $12.95 ($129,500) on September 3, 2026; holds 10,000 after (Direct).
  • Open-market sale: disposed of 10,000 Common Stock at $208.65 ($2,086,500) on September 3, 2026 (Direct).
  • Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on September 3, 2026; holds 104,954 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,086,500 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Mark L. Jacobson — Officer (Chief Operating Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-09-03Option exercise/conversionCommon Stock10,000$13$129.5K10,000
2026-09-03Open-market saleCommon Stock10,000$209$2.1M0
2026-09-03Option exercise/conversionStock Option (Right to Buy)10,000——104,954

Key Dates

DateDescription
2026-09-03Option exercise/conversion (10,000 shares)
2026-09-03Open-market sale (10,000 shares)
2026-09-03Option exercise/conversion (10,000 shares)

Keywords

insider transaction, Form 4, AXSM, Axsome Therapeutics, Inc., bearish, Mark L. Jacobson

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.